Back
ResMed Quote, Financials, Valuation and Earnings
Sponsored
RMD
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
49
RMD
ResMed
Last Price:
245.66
Seasonality Move:
12.46%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeResMed Price Quote
$245.66
-0.08 (0.84%)
(Updated: November 6, 2024 at 5:24 AM ET)
ResMed Key Stats
Sell
49
ResMed (RMD)
is a Sell
Day range:
$241.28 - $246.51
52-week range:
$140.81 - $260.49
Dividend yield:
0.8%
P/E ratio:
35.51
P/S ratio:
7.54
P/B ratio:
6.94%
Volume:
1M
Avg. volume:
1.1M
1-year change:
60.81%
Market cap:
$36.1B
Revenue:
$4.7B
EPS:
$7.55
How Much Does ResMed Make?
Is ResMed Growing As A Company?
ResMed Stock Price Performance
What Is ResMed 52-Week High & Low?
ResMed Price To Free Cash Flow
-
Is ResMed Stock Overvalued?
ResMed is trading at a price to free cash flow ratio of 26.92 -
Is ResMed Stock Undervalued?
ResMed EV to Free Cash Flow ratio is 26.97 -
What Is ResMed’s Price Earnings Growth Ratio?
RMD PEG ratio is 1.44 -
Is ResMed Trading At A Premium To Earnings?
ResMed EV to EBIT ratio is 25.78
Is It Risky To Buy ResMed?
Is ResMed Cash Flow Positive?
ResMed Return On Invested Capital
ResMed Earnings Date & Stock Price
-
What Is ResMed's Stock Price Today?
A single share of RMD can be purchased today for 245.74 -
What Is ResMed’s Stock Symbol?
ResMed trades on the nyse under the ticker symbol: RMD -
When Is ResMed’s Next Earnings Date?
The next quarterly earnings date for ResMed is scheduled on January 24, 2025 -
When Is RMD's next ex-dividend date?
ResMed's next ex-dividend date is November 7, 2024 -
How To Buy ResMed Stock?
You can buy ResMed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ResMed Competitors
ResMed Dividend Yield
ResMed Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 41.61% | 7.69% |
Revenue: | 11.09% | 3.52% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 1 |
Price Target: | 253.39 |
Upside from Last Price: | 3.11% |